Vivos Therapeutics (VVOS) Non-Current Deffered Revenue (2019 - 2025)
Vivos Therapeutics (VVOS) reported Non-Current Deffered Revenue of $1000.0 for Q3 2025, down 99.44% year-over-year from $178000.0 in Q3 2024, and down 80.0% quarter-over-quarter from $5000.0 in Q2 2025.
Vivos Therapeutics (VVOS) Non-Current Deffered Revenue (2019 - 2025) Analysis & Trends
Vivos Therapeutics (VVOS) has 7 years of Non-Current Deffered Revenue data on file, last reported at $1000.0 in Q3 2025.
- Non-Current Deffered Revenue for Q3 2025 came in at $1000.0, down 99.44% year-over-year; the trailing twelve-month figure through Sep 2025 was $1000.0 (down 99.44% YoY), and the FY2024 annual result was $97000.0, down 66.44% from the prior year.
- Non-Current Deffered Revenue declined to $1000.0 in Q3 2025 per VVOS's latest filing, from $5000.0 in the prior quarter.
- Over five years, Non-Current Deffered Revenue peaked at $533000.0 in Q1 2024 and troughed at $1000.0 in Q3 2025.
- A 5-year average of $236235.3 and a median of $250000.0 in 2023 frame the typical range for Non-Current Deffered Revenue.
- The sharpest annual moves came in 2023 and 2025: Non-Current Deffered Revenue surged 158.04% in 2023, then tumbled 99.44% in 2025.
- A 5-year view of Non-Current Deffered Revenue shows it stood at $343000.0 in 2021, then tumbled by 67.35% to $112000.0 in 2022, then surged by 158.04% to $289000.0 in 2023, then sank by 66.44% to $97000.0 in 2024, then tumbled by 98.97% to $1000.0 in 2025.
- Business Quant data shows VVOS's Non-Current Deffered Revenue at $1000.0 in Q3 2025, $5000.0 in Q2 2025, and $22000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 512.79 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Vivos Therapeutics | 7.39 Mn | 5.16 Mn | 3.06 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1,000.00 |
| Jun 30, 2025 | 5,000.00 |
| Mar 31, 2025 | 22,000.00 |
| Dec 31, 2024 | 97,000.00 |
| Sep 30, 2024 | 178,000.00 |
| Jun 30, 2024 | 352,000.00 |
| Mar 31, 2024 | 533,000.00 |
| Dec 31, 2023 | 289,000.00 |
| Sep 30, 2023 | 240,000.00 |
| Jun 30, 2023 | 264,000.00 |
| Mar 31, 2023 | 250,000.00 |
| Dec 31, 2022 | 112,000.00 |
| Sep 30, 2022 | 180,000.00 |
| Jun 30, 2022 | 317,000.00 |
| Mar 31, 2022 | 375,000.00 |
| Dec 31, 2021 | 343,000.00 |
| Sep 30, 2021 | 360,000.00 |
| Jun 30, 2021 | 358,395.00 |
| Mar 31, 2021 | 212,076.00 |
| Dec 31, 2020 | 146,000.00 |